Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Cole Edmonson of AMN Healthcare Honored as Staffing Industry Leader, Named to SIA Staffing 100: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
Cole Edmonson of AMN Healthcare Honored as Staffing Industry Leader, Named to SIA Staffing 100


Cole Edmonson, Chief Clinical Officer of AMN Healthcare (NYSE: AMN), has been honored as one of Staffing Industry Analysts’ 2022 Staffing 100, the leaders of the staffing industry.



The Staffing

Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening:
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening


Agilent Technologies Inc. (NYSE: A) announced today that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a

LivaNova Reports Fourth-Quarter and Full-Year 2021 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2021.



For the fourth quarter of

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2021
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2021
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results:
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the first quarter ended Jan. 31, 2022, an increase of 8% compared to the first quarter of 2021 and up 9% on a core(1)

AMN Healthcare Honors MSP Supplier Partners who Help Provide Healthcare Professionals to Nation’s Hospitals and Health Systems: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Honors MSP Supplier Partners who Help Provide Healthcare Professionals to Nation’s Hospitals and Health Systems


AMN Healthcare, the nation’s leader in total talent solutions for healthcare, today announced the 2021 MSP Supplier Partnership Award winners who help provide quality professionals to AMN Managed

DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care setzt sich Klimaziele: Klimaneutralität bis 2040, Halbierung der CO2-Emissionen bis 2030: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care setzt sich Klimaziele: Klimaneutralität bis 2040, Halbierung der CO2-Emissionen bis 2030
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care setzt sich Klimaziele: Klimaneutralität bis 2040, Halbierung der CO2-Emissionen bis 2030
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care erfüllt Prognose und strebt für 2022 Rückkehr zu Gewinnwachstum an: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care erfüllt Prognose und strebt für 2022 Rückkehr zu Gewinnwachstum an
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care erfüllt Prognose und strebt für 2022 Rückkehr zu Gewinnwachstum an
Chemed Corporation Declares Quarterly Dividend of 36 Cents:
Chemed Corporation Declares Quarterly Dividend of 36 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company’s capital stock, payable on March 18, 2022, to

AMN Healthcare Announces Fourth Quarter and Full Year 2021 Results: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Announces Fourth Quarter and Full Year 2021 Results


AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year

Quidel Reports Fourth Quarter and Full Year 2021 Financial Results
Quidel Reports Fourth Quarter and Full Year 2021 Financial Results


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the

Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity:
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity


Agilent Technologies Inc. (NYSE: A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that

DGAP-HV: Sartorius Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2022 in Göttingen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: Sartorius Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2022 in Göttingen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: Sartorius Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2022 in Göttingen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-News: Gerresheimer AG: Gerresheimer beschleunigt Wachstum und hebt mittelfristige Prognose an
DGAP-News: Gerresheimer AG: Gerresheimer beschleunigt Wachstum und hebt mittelfristige Prognose an
DGAP-News: Gerresheimer AG: Gerresheimer beschleunigt Wachstum und hebt mittelfristige Prognose an
DGAP-News: Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance
DGAP-News: Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance
DGAP-News: Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2021 Earnings Release: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2021 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2021 results on Monday, February 28, 2022, after the close of the market. Acadia

Humana, the Humana Foundation and UofL Announce up to $25 Million Investment in Health Equity Innovation Hub: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana, the Humana Foundation and UofL Announce up to $25 Million Investment in Health Equity Innovation Hub


Humana Inc. (NYSE: HUM), The Humana Foundation and the University of Louisville today announced a new cooperative agreement and additional financial investment in the university’s Health Equity

Forbes Names AMN Healthcare to America’s Best Employers List: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
Forbes Names AMN Healthcare to America’s Best Employers List


AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced it was named among America’s Best Employers for 2022

DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktGhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: Carl Zeiss Meditec AG: Bekanntmachung der Einberufung zur Hauptversammlung am 30.03.2022 in Jena mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Agilent Announces Cash Dividend of 21 Cents per Sharehttps://www.cyansecurity.com/:
Agilent Announces Cash Dividend of 21 Cents per Share


Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on April 27, 2022, to all shareholders of record as of the close of

AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results


AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer: https://mms.businesswire.com/media/20211005005394/en/913083/5/pulse-logo.jpg
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer


Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced the appointment